Galmed Pharmaceuticals Regains Nasdaq Compliance
Company Announcements

Galmed Pharmaceuticals Regains Nasdaq Compliance

Galmed Pharmaceuticals (GLMD) has released an update.

Galmed Pharmaceuticals Ltd. has successfully regained compliance with Nasdaq’s minimum bid price requirement, ensuring its ordinary shares will remain listed on the Nasdaq Stock Market. The company had previously been warned about its stock price falling below $1.00 but managed to maintain a closing bid price above this threshold for the necessary 10 consecutive trading days. This achievement secures the company’s continued presence in the marketplace, offering stability to its investors.

For further insights into GLMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskGalmed Pharmaceuticals Amends Equity Purchase Agreement
TheFlyGalmed files to sell 1M shares of common stock for holders
TipRanks Auto-Generated NewsdeskGalmed Reports Breakthrough in MASH Treatment
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App